Literature DB >> 15788694

Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells.

Takatoshi Shimauchi1, Satoshi Imai, Ryosuke Hino, Yoshiki Tokura.   

Abstract

PURPOSE: Adult T-cell leukemia/lymphoma (ATL) is a peripheral CD4(+)CD25(+) T-cell malignancy caused by human T-cell leukemia virus type I. The tumor cells frequently infiltrate in the skin, lymph nodes and other organs and especially form prominent cutaneous masses. Recently, ATL cells have been shown to express Th2 chemokine receptor CCR4. The aim of this study is to investigate the possibility that CCR4 ligands, thymus and activation-regulated chemokine (TARC) and macrophage-derived chemokine (MDC), are produced by CCR4(+) ATL cells per se. EXPERIMENTAL
DESIGN: CD4(+) or CD4(+)CD14(-) cells were purified from peripheral blood mononuclear cells of 11 ATL patients with cutaneous involvement and normal healthy volunteers. Tissue-infiltrating cells were isolated from skin tumors. The expression of chemokine receptors on these cells were analyzed by flow cytometry. The production of chemokines and cytokines by the neoplastic cells was assessed by ELISA and reverse transcription-PCR after cultivation for 96 hours in the presence or absence of anti-CD3/CD28 monoclonal antibodies. Finally, TARC and CCR4 expressions were examined by immunohistochemistry.
RESULTS: ATL cells highly expressed CCR4 but did not necessarily exhibit the Th2 cytokine profile. The cells also produced TARC and MDC. The production level of MDC was higher in the skin tumor formation group than that in the nontumor group. Immunohistochemically, both CCR4 and TARC were expressed by the tumor cells in the lesional skin.
CONCLUSIONS: ATL cells not only express CCR4 but also produce TARC and MDC. The skin tumor formation as well as the monoclonal integration of proviral DNA are the factors that are associated with the high production of Th2 chemokines by ATL cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15788694     DOI: 10.1158/1078-0432.CCR-04-0491

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  5 in total

1.  Higher circulating levels of chemokine CCL22 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism.

Authors:  A Jafarzadeh; H Fooladseresht; K Minaee; M R Bazrafshani; A Khosravimashizi; M Nemati; M Mohammadizadeh; M M Mohammadi; A Ghaderi
Journal:  Tumour Biol       Date:  2014-10-22

2.  Recurrent Facial Erythema with Cytotoxic T Cell Infiltration as a Possible Reactive Eruption in a Human T-Cell Lymphotropic Virus Type 1 Carrier.

Authors:  Yasuhiro Kaneko; Kazuki Tatsuno; Toshiharu Fujiyama; Taisuke Ito; Yoshiki Tokura
Journal:  Case Rep Dermatol       Date:  2015-05-20

Review 3.  New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma.

Authors:  Kazuyasu Fujii
Journal:  Front Oncol       Date:  2018-06-04       Impact factor: 6.244

Review 4.  The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy.

Authors:  Géraldine Schlecht-Louf; Claire Deback; Françoise Bachelerie
Journal:  Cancers (Basel)       Date:  2022-02-08       Impact factor: 6.639

5.  Genetic Polymorphisms of CCL22 and CCR4 in Patients with Lung Cancer.

Authors:  Nasrollah Erfani; Ahmadi-Sina Nedaei Ahmadi; Mohammad Ali Ghayumi; Zahra Mojtahedi
Journal:  Iran J Med Sci       Date:  2014-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.